EPIZON PHARMA INC has a total of 28 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ZHONGSHAN WANHAN PHARMACY CO LTD, CENTER LABORATORIES INC and SOLUPRIN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tumlin James A | 25 |
#2 | Rudey John M | 23 |
#3 | Darke Paul L | 22 |
#4 | Drouet Keith E | 3 |
#5 | Tumlin James | 1 |
#6 | Drouet Keith | 1 |
Publication | Filing date | Title |
---|---|---|
US2020079718A1 | Menaquinol compositions and methods of treatment | |
US2019374483A1 | Methods and compositions for preventing or treating calciphylaxis | |
EP3801477A1 | Methods and compositions for preventing or treating tissue calcification |